US equities
|
INTC
$119.13
▼-0.17%
MU
$1,074.89
▲+0.00%
NVDA
$233.95
▲+0.00%
SNDK
$1,719.99
▲+0.00%
SDEV
$7.48
▲+0.00%
SPCX
$158.96
▲+0.00%
AMD
$633.91
▲+0.00%
TSLA
$370.59
▲+0.00%
INTC
$119.13
▼-0.17%
MU
$1,074.89
▲+0.00%
NVDA
$233.95
▲+0.00%
SNDK
$1,719.99
▲+0.00%
SDEV
$7.48
▲+0.00%
SPCX
$158.96
▲+0.00%
AMD
$633.91
▲+0.00%
TSLA
$370.59
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
STAAR Surgical Company - Common Stock
(NQ:
STAA
)
22.47
UNCHANGED
Delayed Quote
Updated: 4:00 PM EDT, Oct 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about STAAR Surgical Company - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
1 Cash-Burning Stock for Long-Term Investors and 2 We Turn Down
October 31, 2025
Companies that burn cash at a rapid pace can run into serious trouble if they fail to secure funding. Without a clear path to profitability, these businesses risk dilution, mounting debt, or even...
Via
StockStory
Topics
Bankruptcy
1 Cash-Heavy Stock on Our Buy List and 2 Facing Challenges
October 27, 2025
A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth. Some of these companies also face challenges like stagnating revenue, declining...
Via
StockStory
STAAR Surgical Sets New Record Date and Postpones STAAR Special Meeting of Stockholders in Light of Ongoing Discussions with Alcon
October 27, 2025
From
STAAR Surgical Company
Via
Business Wire
STAAR Surgical Stock Rises After Adjournment Of Stockholders’ Meeting To Discuss Proposed Merger With Alcon
↗
October 23, 2025
Via
Stocktwits
Yunqi Capital Issues Letter to STAAR Surgical Board Opposing Adjournment of the Special Meeting and Calling for the Company to Move Beyond the Proposed Merger with Alcon
October 24, 2025
From
Yunqi Capital Limited
Via
Business Wire
Broadwood Partners Condemns Decision by STAAR Surgical and Alcon to Delay Final Vote on Proposed Transaction
October 24, 2025
From
Broadwood Partners, L.P.
Via
Business Wire
Alcon and STAAR Surgical Announce Adjournment of STAAR Special Meeting of Stockholders
October 23, 2025
From
STAAR Surgical Company
Via
Business Wire
Broadwood Partners Intends to Call Special Meeting to Remove Several STAAR Surgical Directors
October 22, 2025
From
Broadwood Partners, L.P.
Via
Business Wire
Yunqi Capital Issues Letter to STAAR Surgical’s Board Calling for Timely Convening of the Special Meeting to Vote on the Alcon Transaction
October 20, 2025
From
Yunqi Capital Limited
Via
Business Wire
Broadwood Partners Highlights Growing Opposition to STAAR Surgical’s Proposed Sale to Alcon
October 20, 2025
From
Broadwood Partners, L.P.
Via
Business Wire
STAAR Surgical Announces Preliminary Net Sales Results for Third Quarter 2025
October 20, 2025
From
STAAR Surgical Company
Via
Business Wire
3 Unprofitable Stocks We Approach with Caution
October 20, 2025
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, these businesses risk running out of capital...
Via
StockStory
Broadwood Partners Issues Letter to STAAR Surgical’s Board Urging it to Allow Timely Shareholder Vote on Alcon Sale
October 17, 2025
From
Broadwood Partners, L.P.
Via
Business Wire
STAAR Surgical Affirms that No Acquisition Proposals Have Been Received From Any Party Other Than Alcon
October 16, 2025
From
STAAR Surgical Company
Via
Business Wire
Broadwood Partners: All Three Leading Proxy Advisory Firms Recommend STAAR Surgical Shareholders Vote “AGAINST” Sale to Alcon
October 15, 2025
From
Broadwood Partners, L.P.
Via
Business Wire
Broadwood Partners Comments on STAAR Surgical’s Late and Troubling Disclosure in Deeply Flawed Sale Process to Alcon
October 14, 2025
From
Broadwood Partners, L.P.
Via
Business Wire
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates STAA, GES, SMLR on Behalf of Shareholders
October 11, 2025
From
Halper Sadeh LLC
Via
GlobeNewswire
Broadwood Partners Issues Letter to STAAR Surgical’s Board Questioning Its Diligence in Rush to Reaffirm Support for Alcon Sale
October 10, 2025
From
Broadwood Partners, L.P.
Via
Business Wire
STAAR Surgical Board of Directors Reiterates Unanimous Recommendation that STAAR Stockholders Vote “FOR” the Alcon Merger Agreement on WHITE Proxy Card
October 08, 2025
From
STAAR Surgical Company
Via
Business Wire
Broadwood Partners: Leading Advisory Firm Glass Lewis Urges STAAR Shareholders to Vote “AGAINST” Sale to Alcon
October 08, 2025
From
Broadwood Partners, L.P.
Via
Business Wire
STAAR Surgical’s Long-Term Shareholder Says Proposed Deal With Alcon Undervalues The Company
↗
October 07, 2025
Defender Capital, which owns 1.5% of STAAR’s common stock, highlighted STAAR’s board of directors' rejection of Alcon's previous offer of $58 per share in cash.
Via
Stocktwits
Yunqi Capital, One of STAAR Surgical Company’s Largest Shareholders, Reiterates Its Opposition to the Proposed Merger with Alcon
October 06, 2025
From
Yunqi Capital Limited
Via
Business Wire
Broadwood Partners Issues Letter to STAAR Surgical’s Board Questioning Its Judgment in Proposed Sale to Alcon
October 06, 2025
From
Broadwood Partners, L.P.
Via
Business Wire
STAAR Surgical: Independent Industry Analysts Recognize Merits of Alcon Merger, the Value It Provides, and the Downside Risks Facing STAAR on Standalone Basis
October 06, 2025
From
STAAR Surgical Company
Via
Business Wire
STAAR Surgical Addresses Broadwood Partners’ Flawed, Misleading, and Misinformed Claims
October 06, 2025
From
STAAR Surgical Company
Via
Business Wire
3 Unpopular Stocks We Think Twice About
October 06, 2025
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other...
Via
StockStory
Broadwood Partners Publishes Presentation Detailing Opposition to STAAR Surgical’s Sale to Alcon
October 03, 2025
From
Broadwood Partners, L.P.
Via
Business Wire
Alcon and STAAR Surgical Announce Expiration of Hart-Scott-Rodino Waiting Period for Alcon’s Acquisition of STAAR
September 30, 2025
From
Alcon Inc. Investors and STAAR Surgical Company
Via
Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates STAA and CYBR on Behalf of Shareholders
September 27, 2025
From
Halper Sadeh LLC
Via
GlobeNewswire
STAAR Surgical Publishes Presentation Highlighting Compelling, Certain Cash Value Offered by Alcon Merger and Meaningful Downside Risks if Alcon Merger is not Approved
September 26, 2025
From
STAAR Surgical Company
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
